United States (US) Genomics In Cancer Care Market (2025-2031) | Industry, Share, Trends, Value, Segmentation, Analysis, Size & Revenue, Companies, Growth, Competitive Landscape, Outlook, Forecast

Market Forecast By Product Type (Instruments, Consumables, Services), By Technology (PCR, Genome Sequencing, Nucleic Acid Extraction & Purification, Microarray, Others), By Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Others), By End-User (Hospitals, Research Institutes, Others) And Competitive Landscape
Product Code: ETC9966893 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Genomics In Cancer Care Market Outlook
  • Market Size of United States (US) Genomics In Cancer Care Market, 2024
  • Forecast of United States (US) Genomics In Cancer Care Market, 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Revenues & Volume for the Period 2021- 2031
  • United States (US) Genomics In Cancer Care Market Trend Evolution
  • United States (US) Genomics In Cancer Care Market Drivers and Challenges
  • United States (US) Genomics In Cancer Care Price Trends
  • United States (US) Genomics In Cancer Care Porter's Five Forces
  • United States (US) Genomics In Cancer Care Industry Life Cycle
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Product Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Instruments for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Consumables for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Services for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By PCR for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Genome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Nucleic Acid Extraction & Purification for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Microarray for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Personalized Medicine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Drug Discovery & Development for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By End-User for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genomics In Cancer Care Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Genomics In Cancer Care Import Export Trade Statistics
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End-User
  • United States (US) Genomics In Cancer Care Top Companies Market Share
  • United States (US) Genomics In Cancer Care Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Genomics In Cancer Care Company Profiles
  • United States (US) Genomics In Cancer Care Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Genomics In Cancer Care Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Genomics In Cancer Care Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Genomics In Cancer Care Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Genomics In Cancer Care Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Genomics In Cancer Care Market - Industry Life Cycle

3.4 United States (US) Genomics In Cancer Care Market - Porter's Five Forces

3.5 United States (US) Genomics In Cancer Care Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United States (US) Genomics In Cancer Care Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Genomics In Cancer Care Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 United States (US) Genomics In Cancer Care Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 United States (US) Genomics In Cancer Care Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer cases in the United States

4.2.2 Technological advancements in genomics and personalized medicine

4.2.3 Growing demand for precision medicine in cancer treatment

4.3 Market Restraints

4.3.1 High cost associated with genomic testing and personalized treatments

4.3.2 Data privacy and security concerns regarding genomic information

5 United States (US) Genomics In Cancer Care Market Trends

6 United States (US) Genomics In Cancer Care Market, By Types

6.1 United States (US) Genomics In Cancer Care Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Instruments, 2021- 2031F

6.1.4 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Consumables, 2021- 2031F

6.1.5 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Services, 2021- 2031F

6.2 United States (US) Genomics In Cancer Care Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Genomics In Cancer Care Market Revenues & Volume, By PCR, 2021- 2031F

6.2.3 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Genome Sequencing, 2021- 2031F

6.2.4 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Nucleic Acid Extraction & Purification, 2021- 2031F

6.2.5 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Microarray, 2021- 2031F

6.2.6 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Genomics In Cancer Care Market, By Application

6.3.1 Overview and Analysis

6.3.2 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Diagnostics, 2021- 2031F

6.3.3 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Personalized Medicine, 2021- 2031F

6.3.4 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Drug Discovery & Development, 2021- 2031F

6.3.5 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Genomics In Cancer Care Market, By End-User

6.4.1 Overview and Analysis

6.4.2 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.4.4 United States (US) Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Genomics In Cancer Care Market Import-Export Trade Statistics

7.1 United States (US) Genomics In Cancer Care Market Export to Major Countries

7.2 United States (US) Genomics In Cancer Care Market Imports from Major Countries

8 United States (US) Genomics In Cancer Care Market Key Performance Indicators

8.1 Adoption rate of genomic testing in cancer diagnosis and treatment

8.2 Patient outcomes and survival rates post-genomic interventions

8.3 Number of clinical trials incorporating genomics in cancer care

8.4 Investment in research and development for genomics technologies

8.5 Rate of integration of genomic data into electronic health records

9 United States (US) Genomics In Cancer Care Market - Opportunity Assessment

9.1 United States (US) Genomics In Cancer Care Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United States (US) Genomics In Cancer Care Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Genomics In Cancer Care Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 United States (US) Genomics In Cancer Care Market Opportunity Assessment, By End-User, 2021 & 2031F

10 United States (US) Genomics In Cancer Care Market - Competitive Landscape

10.1 United States (US) Genomics In Cancer Care Market Revenue Share, By Companies, 2024

10.2 United States (US) Genomics In Cancer Care Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All